New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Aventis Pharmaceuticals Inc.
Division of Sanofi
www.aventispharma-us.com
Latest From Aventis Pharmaceuticals Inc.
Mallinckrodt Settles Portion Of DOJ's Acthar Gel Kickback Claims; Charity Copay Probe Continues
$15.4m fine will resolve claims of "wining and dining" doctors to get them to prescribe Acthar. Mallinckrodt dropped NORD and switched to Chronic Disease Fund to administer its copay assistance program, a move that Mallinckrodt’s COO purportedly described as "mom & pop vs. WalMart."
Deals Shaping the Medical Industry (12/06)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Deals Shaping the Medical Industry (5/06)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Deals Shaping the Medical Industry (2/06)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Aventis Pharmaceuticals
- Aventis Pharma
- Marion Merrell Dow
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Sanofi
- Senior Management
-
Pierre Legault, SVP, North American Fin. & CFO
Gerald P Belle, Pres.
Jürgen Lasowski, PhD, VP, Bus. Dev. & Strategy - Contact Info
-
Aventis Pharmaceuticals Inc.
Phone: (908) 231-4000
300 Somerset Corporate Boulevard
Bridgewater, NJ 08807-2854
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aventis Pharmaceuticals Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice